Crossmark

A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2

Crossref DOI link: https://doi.org/10.1007/s10549-014-3175-4

Published Online: 2015-01-10

Published Print: 2015-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vachon, Celine M.

Schaid, Daniel J.

Ingle, James N.

Wickerham, D. Lawrence

Kubo, Michiaki

Mushiroda, Taisei

Goetz, Matthew P.

Carlson, Erin E.

Paik, Soonmyung

Wolmark, Norman

Nakamura, Yusuke

Wang, Liewei

Weinshilboum, Richard

Couch, Fergus J.
License Information

Text and Data Mining valid from 2015-01-01